Acyclovir-Induced Nephrotoxicity: The Protective Benefit ofCurcumin

Objective: Nephrotoxicity may decrease the clinical use of acyclovir (ACV). Curcumin (CUM) is used traditionally as treatments for some diseases. This study examined the protective effect of CUM against ACV-induced nephrotoxicity in rats. Materials and Methods: Forty-five male Wistar rats (240–250g) randomized into nine groups (n=5) were used. Group 1(Placebo control) received water (0.2mL/day) intraperitoneally (i.p) whereas group 2 (Solvent control) received corn oil (0.2mL/day) per oral (p.o) for 7 days. Groups 3-5 received CUM (25, 50 and 100 mg/kg/day p.o) for 7 days. Group 6 received ACV (150 mg/kg/day i.p) for 7 days. Groups 7-9 were pre-treated with CUM (25, 50 and 100 mg/kg/day p.o) before the treatment with ACV (150 mg/kg/day i.p) for 7 days. On day 8, the rats were anesthetized; blood samples were collected and evaluated for serum biochemical indices. The k idneys were weighed and assessed for histology and oxidative stress indices. Results: ACV produced no significant (p>0.05) effects on the body and kidney weights of rats when compared to control. ACV caused significant (p

PDF

___

1. Klahr S. Nonexcretory Functions of the Kidney. In: Klahr S. (eds) The Kidney and Body Fluids in Health and Disease. Springer, Boston, MA,1983.
2. Arunvikram K, Mohanty I, Sardar KK, Palai S, Sahoo G, Patra RC. Adverse drug reaction and toxicity caused by commonly used antimicrobials in canine practice. Vet World 2014; 7(5): 299-5.
3. Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, et al. Spectrum of acute renal failure in the intensive care unit: The PICARD experience. Kidney Int 2004; 66: 1613-21.
4. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 2005; 294: 813-8.
5. Bryson YJ, Dillon M, Lovett M, Acuna G, Taylor S, Cherry JD, et al. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N Engl J Med 1983; 308(16): 916-21.
6. Keeney RE, Kirk LE, Bridgen D. Acyclovir tolerance in humans. Am J Med 1982; 73: 176-81.
7. Chou JW, Yong C, Wootton SH. Case 2: Rash, fever and headache first, do no harm. Paediatr Child Heal 2008; 13: 49-2.
8. Genc G, Ozkaya O, Acikgoz Y, Yapici O, Bek K, GulnarSensoy S, et al. Acute renal failure with acyclovir treatment in a child with leukemia. Drug ChemToxicol 2010; 33: 217-19.
9. Bean B, Aeppli D. Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster. J Infect Dis 1985; 151: 362-5.
10. Ahmad T, Simmonds M, McIver AG, McGraw ME. Reversible renal failure in renal transplant patients receiving oral acyclovir prophylaxis. PediatrNephrol 1994; 8: 489-91.
11. Vomiero G, Carpenter B, Robb I, Filler G. Combination of ceftriaxone and acyclovir an underestimated nephrotoxic potential? Pediatr Nephrol 2002; 17: 633-7.
12. Lu H, Han Y-J, Xu J-D, Xing W-M, Chen J. Proteomic Characterization of Acyclovir-Induced Nephrotoxicity in a Mouse Model. PLoS One 2014; 9(7): 1-6.
13. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res 2003; 23: 363-98.
14. Gounder DK, Lingmallu J. Comparison of chemical composition and antioxidant potential of volatile oil from fresh dried and cured turmeric (Curcuma longa) rhizomes. Ind Crops and Prod 2012; 38: 124-31.
15. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: Lessons learned from clinical trials. AAPS J 2013; 15: 195-218.
16. Hewlings SJ, Kalman DS. Curcumin: A review of its’ effects on human health. Foods 2017; 6(92): 1-11.
17. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009; 41: 40-59.
18. El Shemy MA. Protective effects of curcumin against Augmentin-induced hepatotoxicity in rats. Benha Vet MedJ 2018; 35: 375-86.
19. He L, Peng X, Zhu J, Liu G, Chen X, Tang C, et al. Protective effects of curcumin on acute gentamicininduced nephrotoxicity in rats. Can J PhysiolPharmacol 2015; 93(4): 275-82.
20. Miriyala S, Panchatcharam M, Rengarajulu P. Cardioprotective effects of curcumin. AdvExpMed Biol 2007; 595: 359-77.
21. Chakraborty M, Bhattacharjee A, Kamath JV. Cardioprotective effect of curcumin and piperine combination against cyclophosphamide-induced cardiotoxicity. Indian J Pharmacol 2017; 49(1): 65-70.
22. Campos SB, Seguro AC, Cesar KR, Rocha AS. Effects of acyclovir on renal function. Nephron 1992; 62: 74-9.
23. Buege JA, Aust SD. Microsomal lipid peroxidation. Meth Enzymol 1978; 52: 302-10.
24. Aebi H Catalase in vitro. In Method in Enzymology, Colowick SP and Kaplane NO, Eds., New York, NY, USA: Academic Press, 1984.
25. Sun M, Zigman S. An improved spectrophotometer assay of superoxide dismutase based on epinephrine, antioxidation. Anal Biochem 1978; 90: 81-9.
26. Sedlak J, Lindsay RH. Estimation of total, protein-bound and non-protein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 1968; 25: 192-205.
27. Rotruck JT, Rope AL, Ganther HF, Swason AB. Selenium: biochemical role as a component of glutathione peroxidase. Sci 1973; 179: 588-90.
28. Izzedine H, Launay-Vacher V, Deray G. Antiviral drug-induced nephrotoxicity. Am J Kidney Dis 2005; 45: 804-17.
29. Tucker WE Jr, Macklin AW, Szot RJ, Johnston RE, Elion GB, de Miranda P, et al. Preclinical toxicology studies with acyclovir: Acute and subchronic tests. Fund ApplToxicol 1983; 3: 573-8.
30. Agrawal S, Goel RK. Curcumin and its protective and therapeutic uses. Natl J Physiol PharmPharmacol 2016; 6: 1-8.
31. Lu H, Han YJ, Xu JD, Xing WM, Chen J. Proteomic characterization of acyclovir-induced nephrotoxicity in a mouse model. PLoS One 2014; 9 (7): 1-9.
32. Perazella MA, Crystal-induced acute renal failure. Am J Med 1999; 106(4): 459-65.
33. Damiano S, Andretta E, Longobardi C, Prisco F, Paciello O, Squillacioti C, et al. Effects of curcumin on the renal toxicity induced by ochratoxin a in rats. Antioxid 2020; 9(332): 1-13.
34. Huang J, Yao X, Weng G, Qi H and Ye X. Protective effect of curcumin against cyclosporine A-induced rat nephrotoxicity. Mol Med Rep 2018; 17: 6038-44.
35. Chávez-Iñiguez JS, Medina-Gonzalez R, Aguilar-Parra, L. Torres-Vázquez EJ, Maggiani-Aguilera P, Cervantes-Pérez E et al. Oral acyclovir induced hypokalemia and acute tubular necrosis a case report. BMC Nephrol 2018; 19(324): 1-5.
36. Venkatesan N, Punithavathi D, Arumugam V. Curcumin prevents Adriamycin nephrotoxicity in rats. Br J Pharmacol 2000;129: 231-4.
37. Whitley RJ, Middlebrooks M, Gnann JW, Jr. Acyclovir: The past ten years. Adv Exp Med Biol 1990; 278: 243-53.
38. Dennis JM, Witting PK. Protective role for antioxidants in acute kidney disease. Nutr 2017; 9(7): 718.
39. Gaschler MM, Stockwell BR. Lipid peroxidation in cell death. BiochemBiophys Res Commun 2017; 15(482): 419-25.
40. Tirkey N, Kaur G, Vij G, Chopra K. Curcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys. BMC Pharmacol 2005; 5(15): 1-10.
41. Palipoch S, Punsawad C, Chinnapun D, Suwannalert P. Amelioration of cisplatin-induced nephrotoxicity in rats by curcumin and α-tocopherol. Trop J Pharm Res 2013; 12: 973-9.
42. Yadav VR, Suresh S, Devi K, Yadav S. Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model APPS Pharm Sci Tech 2009; 10: 752-62.
43. Maheshwari RK, Singh AK. Multiple biological activities of curcumin: a short review LifeSci 2006; 78: 2081-7.
44. Priyadarsini KI, Maity DK, Naik, GH, Kumar MS, Unnikrishnan MK, Satav JG, et al. Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin. Free RadicBiol Med 2003; 35: 475-84.
45. Lin YG, Kunnumakkara AB, Nair A, Merritt WM, Han LY, Armaiz-Pena GN, et al. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-κB pathway. Clin Cancer Res 2007; 13: 3423-30.
46. Marchiani A, Rozzo C, Fadda A, Delogu G, Ruzza P. Curcumin and curcumin-like molecules: From spice to drugs. Curr Med Chem 2014; 21: 204-22.
47. Kohli K, Ali J, Ansari MJ, Raheman Z. Curcumin: A natural anti-inflammatory agent. Indian J Pharmacol 2005; 37: 141-7.